Supplementary Table 1. Baseline characteristics of patients with dermatomyositis who received COVID-19 vaccination by disease flare status
Published: 21 September 2022| Version 1 | DOI: 10.17632/783fstrwtm.1
Contributors:
Catherina Pan, , Daniel Kim, Rachael Rowley, Morgan Shaefer, Avery LaChance, Vinod NambudiriDescription
Characteristics of patients with dermatomyositis who did and did not have disease flare after COVID-19 vaccination
Files
Categories
Dermatology, Dermatomyositis, Vaccination, COVID-19